Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems
1/7/19: "We are committed to expanding our business beyond blood glucose monitoring and we see continuous glucose monitoring as a critical component of diabetes care. This partnership will enable us to bring an approved CGM product to selected markets in 2019 and at the same time create novel CGM systems that build on POCTech's existing technology to address some of the unmet needs of people with diabetes," said Michael Kloss, CEO, Ascensia Diabetes Care.
Study Presented at Diabetes Technology Meeting Showing That Usage of Contour®Diabetes App May Reduce the Chance of Hypoglycemic and Hyperglycemic Events in People With Diabetes
11/8/18: The study was presented today as a poster1 at the Diabetes Technology Meeting in Bethesda, Maryland by Andreas Stuhr, M.D., Head of Global Medical Affairs and lead author. It examined the impact of usage of the CONTOUR®DIABETES app on the likelihood of hypo- and hyperglycemic events. It also assessed testing frequency in people with diabetes for the first 30 days and after 180 days of app use.